The nasal spray had to go through many rounds of clinical testing, with some shown to improve depression, while others showed no improvement over a placebo. In 2019, the FDA approved Spravato for ...

Health Canada approves Hikma Pharma’s Kloxxado nasal spray 8 mg for treatment of known or suspected opioid overdose: London Monday, March 24, 2025, 13:00 Hrs [IST] Hikma Pharmac ...

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...

A nasal spray, referred to as nasal anti-CD3 ... “It goes beyond their discharge, with all the spectrum of PTSD, anxiety, depression, and cognitive decline.” Following successful trials ...

The trailer for Season 27 of South Park has been released, and the animated satirical sitcom appears to have a new target: Elon Musk. Newsweek has reached out to X outside of normal working hours via ...

Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...